Target intelligence / Profile preview

Vacuolar proton pump subunit G2 (ATP6V1G2)

Target
ATP6V1G2
Molecular classification
Enzyme (specifically, ATPase), Proton transporter (vacuolar H+-ATPase subunit), Component of the V-ATPase multimeric proton pump complex
01

Overview

ATP6V1G2 encodes subunit G2 of the V1 domain of vacuolar H+-ATPase (V-ATPase), a multisubunit ATP-dependent proton pump critical for acidifying intracellular compartments such as lysosomes, endosomes, and synaptic vesicles[1][3][5][6]. The V1 sector, where G2 localizes, is responsible for ATP hydrolysis, which energizes proton translocation via the V0 membrane domain. The G2 isoform is selectively expressed in neurons, where it supports neurotransmitter loading into synaptic vesicles—a key step for synaptic transmission. More broadly, V-ATPase-dependent acidification is crucial for protein processing, immune responses, and receptor-mediated endocytosis. Disruption of V-ATPase function, including mutations or altered expression of ATP6V1G2, has been implicated in neurological dysfunction and potentially in immune system modulation[3][5][6]. Essential details: - Subunit G2 is a ~13 kDa protein forming part of the peripheral stalk that connects V1 and V0 domains, contributing to enzyme structural integrity and regulatory dissociation/association cycles[5]. - In mammals, three genes encode G subunit isoforms (ATP6V1G1, ATP6V1G2, ATP6V1G3), with ATP6V1G2 predominantly neuronal[5]. - Mutations or loss of ATP6V1G2 can impact synaptic physiology and may contribute to neurodevelopmental or degenerative diseases[3][5]. - While the entire V-ATPase complex is a validated therapeutic target (e.g., for osteoporosis, cancer, viral infections), subunit-specific targeting has not been achieved as of the available evidence.

Other names
V-type proton ATPase subunit G2ATP6V1G2ATP6GATP6G2NG38Vma10V-ATPase subunit G2V-ATPase 13 kDa subunit 2Vacuolar ATP synthase subunit G2Vacuolar proton pump G subunit 2Em:AC004181.3
02

Mechanism of action

General V-ATPase inhibitors decrease acidification of intracellular vesicles, thus interfering with protein degradation, neurotransmitter loading, or viral entry

03

Biological functions

Acidification of intracellular compartmentsSynaptic vesicle proton gradient generation (neurotransmitter storage/release)Protein sortingZymogen activationReceptor-mediated endocytosisRegulation of vesicular traffickingImmune response modulation[1][3][5]
04

Disease associations

Neurodegenerative diseaseNeurodevelopmental disorders (due to altered neurotransmitter storage)Disorders of lysosomal acidificationPotential inflammation modulation
05

Safety considerations

Inhibition of V-ATPases can broadly disrupt cellular homeostasis, leading to lysosomal dysfunction, impaired neurotransmission, and metabolic acidosisPotential for off-target effects on other V-ATPase subunits expressed in multiple tissues[2][5]
06

Interacting drugs

None known to directly target ATP6V1G2 specifically. Some drugs may inhibit V-ATPases as a whole (e.g., bafilomycin A1), but clinical drugs specific for this subunit have not been described in the search results.
07

Biomarkers

None specific to ATP6V1G2, but altered lysosomal acidification markers or synaptic vesicle function markers may indirectly reflect its activity[5]

Beyond the preview

Go deeper on Vacuolar proton pump subunit G2 (ATP6V1G2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vacuolar proton pump subunit G2 (ATP6V1G2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call